Anand K P, Patro Swadheena, Mohapatra Abhijita, Mishra Sumita
Reader, Department of Endodontics, Yashwantrao Chawan Dental College , Ahmednagar, Maharashtra, India .
Reader, Department of Endodontics, Institute of Dental Sciences , Bhubaneswar, India .
J Clin Diagn Res. 2015 Sep;9(9):ZC25-8. doi: 10.7860/JCDR/2015/11267.6464. Epub 2015 Sep 1.
Alveolar osteitis (AO) is an important postoperative problem with an incidence of 20% to 35% especially prevalent after the removal of mandibular molars. Fibrinolysis with subsequent loss of blood clotting is believed to be the general cause of AO.
This study aims to evaluate the efficacy of tranexamic acid, an antifibrinolytic agent in comparison with a placebo with respect to the reduction of incidence of AO after the extraction of mandibular molars by using following parameters: Pain, disintegration of Clot, halitosis.
A double blind study consisted of 60 patients, who underwent routine dental extractions of mandibular molar teeth. Group A (30 patients) requiring routine dental extractions of mandibular teeth was randomly selected and was administered a dose of tranexamic acid orally (Pause 500mg) one hour prior to extraction of teeth. Gel foam soaked in tranexamic acid (160mg) was placed into the extraction socket postoperatively. A figure of eight silk suture was placed over the socket to secure the gelfoam. Group B (30 patients); a placebo (crocin) was given orally one hour prior to the extraction and gel foam soaked in saline was placed into the extraction socket postoperatively. A figure of eight silk suture was placed over the socket. Pain was rated individually by each patient at 3(rd), 7(th), 14(th) day after extraction and the results was statistically analysed.
This study supports that the use of tranexamic acid both locally and systemically following the removal of the teeth reduces the incidence of AO associated with the extraction of mandibular molars.
Tranexamic acid has several advantages also when used for simple dental extractions, namely: low cost and ready availability and therefore we recommend this treatment modality.
牙槽骨炎(AO)是一个重要的术后问题,发生率为20%至35%,在下颌磨牙拔除术后尤为常见。纤维蛋白溶解及随后的凝血功能丧失被认为是AO的主要病因。
本研究旨在通过以下参数评估抗纤维蛋白溶解剂氨甲环酸与安慰剂相比,在下颌磨牙拔除后降低AO发生率的疗效:疼痛、血凝块溶解、口臭。
一项双盲研究纳入了60例行下颌磨牙常规拔牙的患者。随机选择需要进行下颌牙常规拔牙的A组(30例患者),在拔牙前1小时口服一剂氨甲环酸(500mg)。术后将浸泡在氨甲环酸(160mg)中的明胶海绵放入拔牙窝。在牙槽窝上方放置一个8字形丝线缝合以固定明胶海绵。B组(30例患者):在拔牙前1小时口服安慰剂(对乙酰氨基酚),术后将浸泡在盐水中的明胶海绵放入拔牙窝。在牙槽窝上方放置一个8字形丝线缝合。每位患者在拔牙后第3、7、14天分别对疼痛进行评分,并对结果进行统计学分析。
本研究支持拔牙后局部和全身使用氨甲环酸可降低下颌磨牙拔除相关的AO发生率。
氨甲环酸用于简单拔牙时也有几个优点,即:成本低且易于获得,因此我们推荐这种治疗方式。